SALE
市場調查報告書

血肌酐化驗的全球市場:至2025年的預測與市場機會

Global Creatinine Assay Market By Disease, By Method,By Kit, By Sample (Serum, Urine, Cerebrospinal fluid, Others), By End-User, By Company, By Region, Forecast & Opportunities, 2025

出版商 TechSci Research 商品編碼 938723
出版日期 內容資訊 英文 114 Pages
商品交期: 請詢問到貨日
價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

血肌酐化驗的全球市場:至2025年的預測與市場機會 Global Creatinine Assay Market By Disease, By Method,By Kit, By Sample (Serum, Urine, Cerebrospinal fluid, Others), By End-User, By Company, By Region, Forecast & Opportunities, 2025
出版日期: 2020年05月01日內容資訊: 英文 114 Pages
簡介

血肌酐,是由肌肉生成的廢物之一。由肌肉代謝生成,從尿液排出。血肌酐化驗,顯示體內存在的血肌酐等級和腎臟的健康狀態。 隨著罹患慢性腎臟病和其他腎障礙的患者增加,腎功能檢驗的技術進步與創新,推動全球血肌酐化驗市場。

本報告提供各市場區隔和各地區全球血肌酐化驗市場調查,市場規模及市場佔有率的預測,推動因素與課題,市場趨勢,競爭情形,企業簡介等資訊。

目錄

第1章 產品概要

第2章 調查手法

第3章 摘要整理

第4章 客戶的迴響

第5章 全球血肌酐化驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各疾病(第一型糖尿病,第二型糖尿病,腎臟病,其他)
    • 各方法(O'Leary modified Jaffe assay,Jaffe法,酵素實驗)
    • 各套件(血肌酐-pap試驗套件,ELISA試驗套件,Kinetic Jaffe法的套件,血肌酐比色法/螢光法化驗套件)
    • 各樣品(血清,尿,腦脊髓液(CSF),其他)
    • 各終端用戶(醫院、診所,診斷研究所,其他)
    • 各企業(2019)
    • 各地區
  • 市場魅力指數

第6章 亞太地區的血肌酐化驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各疾病
    • 各方法
    • 各套件
    • 各樣品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 亞太地區:國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 新加坡
    • 澳洲

第7章 歐洲的血肌酐化驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各疾病
    • 各方法
    • 各套件
    • 各樣品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 歐洲:國家分析
    • 法國
    • 德國
    • 英國
    • 義大利

第8章 北美的血肌酐化驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各疾病
    • 各方法
    • 各套件
    • 各樣品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 北美:國家分析
    • 美國
    • 墨西哥
    • 加拿大

第9章 南美的血肌酐化驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各疾病
    • 各方法
    • 各套件
    • 各樣品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 南美:國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第10章 中東和非洲的血肌酐化驗市場展望

  • 市場規模與預測
  • 市場佔有率與預測
    • 各疾病
    • 各方法
    • 各套件
    • 各樣品
    • 各終端用戶
    • 各國
  • 市場魅力指數
  • 中東、非洲:國家分析
    • 南非
    • 沙烏地阿拉伯
    • UAE

第11章 市場動態

  • 促進因素
  • 阻礙因素

第12章 市場趨勢與趨勢

第13章 競爭情形

  • 競爭的展望
  • 企業簡介
    • BioVision
    • Thermo Fisher Scientific
    • Merck
    • Bioassay Systems
    • Cell Biolabs
    • Fujifilm
    • Quidel Corporation
    • Enzo Life Sciences
    • Tulip Diagnostics
    • Genway Biotech
    • Crystal Chem
    • Randox Laboratories
    • Nova Biomedical
    • Cayman Chemical
    • Pfizer
    • DiaSys Diagnostic Systems
    • Abbexa
    • MedTest DX
    • Roche
    • Abcam

第14章 策略性推薦事項

第15章 免責聲明

目錄
Product Code: 4535

Creatinine is a kind of waste product produced by the muscles. It is produced as a result of muscle metabolism and is eliminated through the urine. Sometimes, creatinine is produced due to excessive consumption of meat, especially red meat. A creatinine assay indicates the level of creatinine present in the body and the status of the kidney health.

Generally, the level of creatinine varies from 0.5 to 1.2 milligrams (mg) per deciliter (dL). The level of creatinine varies in male and female and is generally high in males. The normal range of creatinine in the blood are approximately 0.6 to 1.2 milligrams (mg) per deciliter (dL) in adult males and 0.5 to 1.1 milligrams per deciliter in adult females. Beyond this range, any value is indictive of poor glomerular filtration rate and kidney impairment.

Global creatinine assay market is expected to grow at a formidable rate during the forecast period. The global creatinine assay market is driven by the technological advancements and innovations in the field of kidney function testing on account of the growing number of patients suffering from chronic kidney disease or other renal impairments. Additionally, growing awareness among the population pertaining to adoption of preventive healthcare is further expected to propel the market during forecast years. Furthermore, supportive government initiatives & policies for promoting renal health awareness is anticipated to foster the growth over 2025.

The global creatinine assay market can be segmented based on disease, method, kit, sample, end user, company and region. Based on disease, the market can be categorized into type 1 diabetes, type 2 diabetes, kidney disease and others. The kidney disease segment is expected to dominate the market during the forecast period. This can be accredited to the increasing prevalence of renal diseases. Additionally, creatinine assay is majorly and more frequently done in kidney disease as compared to diabetes wherein creatinine assay is generally done once or twice a year depending upon the condition. While, in case of any renal disease, the creatinine assay is done on a regular basis.

Regionally, the creatinine assay market has been segmented into Asia-Pacific, North America, South America, Europe, and Middle East & Africa. Among these regions, North America is expected to dominate the market during forecast period. This can be attributed to the presence of a large geriatric population base in the country. Additionally, the presence of key players in the region is further expected to propel the market through 2025.

Major players operating in the global creatinine assay market include BioVision, Thermo Fisher Scientific, Merck, Bioassay Systems, Cell Biolabs, Fujifilm, Quidel Corporation, Enzo Life Sciences, Tulip Diagnostics, Genway Biotech, Crystal Chem, Randox Laboratories, Nova Biomedical, Cayman Chemical, Pfizer, DiaSys Diagnostic Systems, Abbexa, MedTest DX, Roche, Abcam and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of global creatinine assay market.
  • To classify and forecast global creatinine assay market based on disease, method, kit, sample, end user, company and regional distribution.
  • To identify drivers and challenges for global creatinine assay market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global creatinine assay market.
  • To identify and analyze the profile of leading players operating in global creatinine assay market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global creatinine assay market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Creatinine assay kits manufacturers, suppliers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to creatinine assay
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global creatinine assay market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Disease:

Type 1 Diabetes

Type 2 Diabetes

Kidney disease

Others

  • Market, By Method:

O'Leary modified Jaffe assay

Jaffe

Enzymatic

  • Market, By Kit:

Creatinine-pap test kits

ELISA test kits

Jaffe's kinetic test kits

Creatinine Colorimetric/Fluorometric Assay Kit

  • Market, By Sample:

Serum

Urine

Cerebrospinal fluid (CSF)

Others

  • Market, By End User:

Hospitals and clinics

Diagnostic laboratories

Others

  • Market, By Region:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • France
  • United Kingdom
  • Italy

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia

Middle East & Africa

  • South Africa
  • Saudi Arabia
  • UAE

South America

  • Brazil
  • Argentina
  • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global creatinine assay market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. Global Creatinine Assay Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value & Volume
  • 5.2. Market Share & Forecast
    • 5.2.1. By Disease (Type 1 Diabetes, Type 2 Diabetes, Kidney disease, Others)
    • 5.2.2. By Method (O'Leary modified Jaffe assay, Jaffe, Enzymatic)
    • 5.2.3. By Kit (Creatinine-pap test kits, ELISA test kits, Jaffe's kinetic test kits, Creatinine Colorimetric/Fluorometric Assay Kit)
    • 5.2.4. By Sample (Serum, Urine, Cerebrospinal fluid (CSF), Others)
    • 5.2.5. By End-User (Hospitals and clinics, Diagnostic laboratories, Others)
    • 5.2.6. By Company (2019)
    • 5.2.7. By Region
  • 5.3. Market Attractiveness Index

6. Asia-Pacific Creatinine Assay Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value & Volume
  • 6.2. Market Share & Forecast
    • 6.2.1. By Disease
    • 6.2.2. By Method
    • 6.2.3. By Kit
    • 6.2.4. By Sample
    • 6.2.5. By End-User
    • 6.2.6. By Country
  • 6.3. Market Attractiveness Index
  • 6.4. Asia-Pacific: Country Analysis
    • 6.4.1. China Creatinine Assay Market Outlook
      • 6.4.1.1. Market Size & Forecast
        • 6.4.1.1.1. By Value
      • 6.4.1.2. Market Share & Forecast
        • 6.4.1.2.1. By Disease
        • 6.4.1.2.2. By Method
        • 6.4.1.2.3. By Kit
        • 6.4.1.2.4. By Sample
        • 6.4.1.2.5. By End-User
    • 6.4.2. India Creatinine Assay Market Outlook
      • 6.4.2.1. Market Size & Forecast
        • 6.4.2.1.1. By Value
      • 6.4.2.2. Market Share & Forecast
        • 6.4.2.2.1. By Disease
        • 6.4.2.2.2. By Method
        • 6.4.2.2.3. By Kit
        • 6.4.2.2.4. By Sample
        • 6.4.2.2.5. By End-User
    • 6.4.3. Japan Creatinine Assay Market Outlook
      • 6.4.3.1. Market Size & Forecast
        • 6.4.3.1.1. By Value
      • 6.4.3.2. Market Share & Forecast
        • 6.4.3.2.1. By Disease
        • 6.4.3.2.2. By Method
        • 6.4.3.2.3. By Kit
        • 6.4.3.2.4. By Sample
        • 6.4.3.2.5. By End-User
    • 6.4.4. South Korea Creatinine Assay Market Outlook
      • 6.4.4.1. Market Size & Forecast
        • 6.4.4.1.1. By Value
      • 6.4.4.2. Market Share & Forecast
        • 6.4.4.2.1. By Disease
        • 6.4.4.2.2. By Method
        • 6.4.4.2.3. By Kit
        • 6.4.4.2.4. By Sample
        • 6.4.4.2.5. By End-User
    • 6.4.5. Singapore Creatinine Assay Market Outlook
      • 6.4.5.1. Market Size & Forecast
        • 6.4.5.1.1. By Value
      • 6.4.5.2. Market Share & Forecast
        • 6.4.5.2.1. By Disease
        • 6.4.5.2.2. By Method
        • 6.4.5.2.3. By Kit
        • 6.4.5.2.4. By Sample
        • 6.4.5.2.5. By End-User
    • 6.4.6. Australia Creatinine Assay Market Outlook
      • 6.4.6.1. Market Size & Forecast
        • 6.4.6.1.1. By Value
      • 6.4.6.2. Market Share & Forecast
        • 6.4.6.2.1. By Disease
        • 6.4.6.2.2. By Method
        • 6.4.6.2.3. By Kit
        • 6.4.6.2.4. By Sample
        • 6.4.6.2.5. By End-User

7. Europe Creatinine Assay Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value & Volume
  • 7.2. Market Share & Forecast
    • 7.2.1. By Disease
    • 7.2.2. By Method
    • 7.2.3. By Kit
    • 7.2.4. By Sample
    • 7.2.5. By End-User
    • 7.2.6. By Country
  • 7.3. Market Attractiveness Index
  • 7.4. Europe: Country Analysis
    • 7.4.1. France Creatinine Assay Market Outlook
      • 7.4.1.1. Market Size & Forecast
        • 7.4.1.1.1. By Value
      • 7.4.1.2. Market Share & Forecast
        • 7.4.1.2.1. By Disease
        • 7.4.1.2.2. By Method
        • 7.4.1.2.3. By Kit
        • 7.4.1.2.4. By Sample
        • 7.4.1.2.5. By End-User
    • 7.4.2. Germany Creatinine Assay Market Outlook
      • 7.4.2.1. Market Size & Forecast
        • 7.4.2.1.1. By Value
      • 7.4.2.2. Market Share & Forecast
        • 7.4.2.2.1. By Disease
        • 7.4.2.2.2. By Method
        • 7.4.2.2.3. By Kit
        • 7.4.2.2.4. By Sample
        • 7.4.2.2.5. By End-User
    • 7.4.3. United Kingdom Creatinine Assay Market Outlook
      • 7.4.3.1. Market Size & Forecast
        • 7.4.3.1.1. By Value
      • 7.4.3.2. Market Share & Forecast
        • 7.4.3.2.1. By Disease
        • 7.4.3.2.2. By Method
        • 7.4.3.2.3. By Kit
        • 7.4.3.2.4. By Sample
        • 7.4.3.2.5. By End-User
    • 7.4.4. Italy Creatinine Assay Market Outlook
      • 7.4.4.1. Market Size & Forecast
        • 7.4.4.1.1. By Value
      • 7.4.4.2. Market Share & Forecast
        • 7.4.4.2.1. By Disease
        • 7.4.4.2.2. By Method
        • 7.4.4.2.3. By Kit
        • 7.4.4.2.4. By Sample
        • 7.4.4.2.5. By End-User

8. North America Creatinine Assay Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value & Volume
  • 8.2. Market Share & Forecast
    • 8.2.1. By Disease
    • 8.2.2. By Method
    • 8.2.3. By Kit
    • 8.2.4. By Sample
    • 8.2.5. By End-User
    • 8.2.6. By Country
  • 8.3. Market Attractiveness Index
  • 8.4. North America: Country Analysis
    • 8.4.1. United States Creatinine Assay Market Outlook
      • 8.4.1.1. Market Size & Forecast
        • 8.4.1.1.1. By Value
      • 8.4.1.2. Market Share & Forecast
        • 8.4.1.2.1. By Disease
        • 8.4.1.2.2. By Method
        • 8.4.1.2.3. By Kit
        • 8.4.1.2.4. By Sample
        • 8.4.1.2.5. By End-User
    • 8.4.2. Mexico Creatinine Assay Market Outlook
      • 8.4.2.1. Market Size & Forecast
        • 8.4.2.1.1. By Value
      • 8.4.2.2. Market Share & Forecast
        • 8.4.2.2.1. By Disease
        • 8.4.2.2.2. By Method
        • 8.4.2.2.3. By Kit
        • 8.4.2.2.4. By Sample
        • 8.4.2.2.5. By End-User
    • 8.4.3. Canada Creatinine Assay Market Outlook
      • 8.4.3.1. Market Size & Forecast
        • 8.4.3.1.1. By Value
      • 8.4.3.2. Market Share & Forecast
        • 8.4.3.2.1. By Disease
        • 8.4.3.2.2. By Method
        • 8.4.3.2.3. By Kit
        • 8.4.3.2.4. By Sample
        • 8.4.3.2.5. By End-User

9. South America Creatinine Assay Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value & Volume
  • 9.2. Market Share & Forecast
    • 9.2.1. By Disease
    • 9.2.2. By Method
    • 9.2.3. By Kit
    • 9.2.4. By Sample
    • 9.2.5. By End-User
    • 9.2.6. By Country
  • 9.3. Market Attractiveness Index
  • 9.4. South America: Country Analysis
    • 9.4.1. Brazil Creatinine Assay Market Outlook
      • 9.4.1.1. Market Size & Forecast
        • 9.4.1.1.1. By Value
      • 9.4.1.2. Market Share & Forecast
        • 9.4.1.2.1. By Disease
        • 9.4.1.2.2. By Method
        • 9.4.1.2.3. By Kit
        • 9.4.1.2.4. By Sample
        • 9.4.1.2.5. By End-User
    • 9.4.2. Argentina Creatinine Assay Market Outlook
      • 9.4.2.1. Market Size & Forecast
        • 9.4.2.1.1. By Value
      • 9.4.2.2. Market Share & Forecast
        • 9.4.2.2.1. By Disease
        • 9.4.2.2.2. By Method
        • 9.4.2.2.3. By Kit
        • 9.4.2.2.4. By Sample
        • 9.4.2.2.5. By End-User
    • 9.4.3. Colombia Creatinine Assay Market Outlook
      • 9.4.3.1. Market Size & Forecast
        • 9.4.3.1.1. By Value
      • 9.4.3.2. Market Share & Forecast
        • 9.4.3.2.1. By Disease
        • 9.4.3.2.2. By Method
        • 9.4.3.2.3. By Kit
        • 9.4.3.2.4. By Sample
        • 9.4.3.2.5. By End-User

10. Middle East and Africa Creatinine Assay Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value & Volume
  • 10.2. Market Share & Forecast
    • 10.2.1. By Disease
    • 10.2.2. By Method
    • 10.2.3. By Kit
    • 10.2.4. By Sample
    • 10.2.5. By End-User
    • 10.2.6. By Country
  • 10.3. Market Attractiveness Index
  • 10.4. MEA: Country Analysis
    • 10.4.1. South Africa Creatinine Assay Market Outlook
      • 10.4.1.1. Market Size & Forecast
        • 10.4.1.1.1. By Value
      • 10.4.1.2. Market Share & Forecast
        • 10.4.1.2.1. By Disease
        • 10.4.1.2.2. By Method
        • 10.4.1.2.3. By Kit
        • 10.4.1.2.4. By Sample
        • 10.4.1.2.5. By End-User
    • 10.4.2. Saudi Arabia Creatinine Assay Market Outlook
      • 10.4.2.1. Market Size & Forecast
        • 10.4.2.1.1. By Value
      • 10.4.2.2. Market Share & Forecast
        • 10.4.2.2.1. By Disease
        • 10.4.2.2.2. By Method
        • 10.4.2.2.3. By Kit
        • 10.4.2.2.4. By Sample
        • 10.4.2.2.5. By End-User
    • 10.4.3. UAE Creatinine Assay Market Outlook
      • 10.4.3.1. Market Size & Forecast
        • 10.4.3.1.1. By Value
      • 10.4.3.2. Market Share & Forecast
        • 10.4.3.2.1. By Disease
        • 10.4.3.2.2. By Method
        • 10.4.3.2.3. By Kit
        • 10.4.3.2.4. By Sample
        • 10.4.3.2.5. By End-User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

  • 13.1. Competition Outlook
  • 13.2. Players Profiled (Leading Companies)
    • 13.2.1. BioVision
    • 13.2.2. Thermo Fisher Scientific
    • 13.2.3. Merck
    • 13.2.4. Bioassay Systems
    • 13.2.5. Cell Biolabs
    • 13.2.6. Fujifilm
    • 13.2.7. Quidel Corporation
    • 13.2.8. Enzo Life Sciences
    • 13.2.9. Tulip Diagnostics
    • 13.2.10. Genway Biotech
    • 13.2.11. Crystal Chem
    • 13.2.12. Randox Laboratories
    • 13.2.13. Nova Biomedical
    • 13.2.14. Cayman Chemical
    • 13.2.15. Pfizer
    • 13.2.16. DiaSys Diagnostic Systems
    • 13.2.17. Abbexa
    • 13.2.18. MedTest DX
    • 13.2.19. Roche
    • 13.2.20. Abcam

14. Strategic Recommendations

15. About Us & Disclaimer